Get Started Average Weight Loss of 10lbs in First Two Months* *Based on self-reported data from Innovative Care patients on a personalized treatment plan including compounded GLP-1 injections, along with a reduced calorie diet and exercise
The dismissal followed a newly announced collaboration between the companies. Under the agreement, Hims & Hers will begin offering Novo Nordisks FDA-approved GLP-1 medications including Ozempic and Wegovy on its telehealth platform later this month
Morbidity and Mortality Weekly Report , 65 (45), 12651269
Having an oral formulation, it may lower the psychological barrier that patients have to starting treatment, says Priya Jaisinghani, MD, an endocrinologist and obesity-medicine specialist at New York University Langone Medical Associates and a clinical assistant professor at NYUs Grossman School of Medicine
Schedule a consultation today